ProfileGDS5678 / 1444134_at
TitleAnti-VEGF and Anti-Notch treatment effect on U87 glioblastoma xenograft tumors [Mouse430_2]
OrganismMus musculus


control bevacizumab dibenzazepine GSM967852 GSM967853 GSM967854 GSM967855 GSM967856 GSM967862 GSM967863 GSM967864 GSM967865 GSM967857 GSM967858 GSM967859 GSM967860 GSM967861 26% 17% 17% 13% 19% 18% 16% 24% 21% 19% 18% 16% 28% 24% sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM967852U87-EV human glioblastoma xenograft - Control 12.628626
GSM967853U87-EV human glioblastoma xenograft - Control 22.417517
GSM967854U87-EV human glioblastoma xenograft - Control 32.4197117
GSM967855U87-EV human glioblastoma xenograft - Control 42.2688113
GSM967856U87-EV human glioblastoma xenograft - Control 52.4119419
GSM967862U87-EV human glioblastoma xenograft - Bevacizumab treated 12.5041218
GSM967863U87-EV human glioblastoma xenograft - Bevacizumab treated 22.4306116
GSM967864U87-EV human glioblastoma xenograft - Bevacizumab treated 32.543324
GSM967865U87-EV human glioblastoma xenograft - Bevacizumab treated 42.4695821
GSM967857U87-EV human glioblastoma xenograft - dibenzazepine treated 12.4376619
GSM967858U87-EV human glioblastoma xenograft - dibenzazepine treated 22.4289318
GSM967859U87-EV human glioblastoma xenograft - dibenzazepine treated 32.3580716
GSM967860U87-EV human glioblastoma xenograft - dibenzazepine treated 42.6356328
GSM967861U87-EV human glioblastoma xenograft - dibenzazepine treated 52.5604224